News
In response to a request from the European Medicines Agency (EMA) following the death of a 16-year-old patient in the U.S., ...
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say ...
Louisville Public Media on MSN8d
Eli Lilly's Alzheimer's drug not recommended by top European regulatorEli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...
The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...
The Associated Press on MSN13d
European committee says Lilly Alzheimer's drug shouldn't get marketing approvalThe European Medicines Agency committee said the benefits of the new drug, Kisunla, did not outweigh the risks, and it ...
The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term ...
SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback